These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 33006785)
21. SQLE-a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration. Zhao YC; Li YF; Qiu L; Jin SZ; Shen YN; Zhang CH; Cui J; Wang TJ BMC Cancer; 2024 Sep; 24(1):1133. PubMed ID: 39261819 [TBL] [Abstract][Full Text] [Related]
22. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma. Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721 [TBL] [Abstract][Full Text] [Related]
23. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer. Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145 [TBL] [Abstract][Full Text] [Related]
24. Identification of pathology-specific regulators of m Li N; Zhan X EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929 [TBL] [Abstract][Full Text] [Related]
25. ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification. Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B Curr Gene Ther; 2024; 24(5):441-452. PubMed ID: 38441026 [TBL] [Abstract][Full Text] [Related]
26. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer. Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X Front Immunol; 2022; 13():976107. PubMed ID: 36091006 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer. Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014 [TBL] [Abstract][Full Text] [Related]
28. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma. Fu Y; Sun S; Bi J; Kong C; Yin L Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886 [TBL] [Abstract][Full Text] [Related]
29. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma. Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y Front Genet; 2020; 11():994. PubMed ID: 33193582 [TBL] [Abstract][Full Text] [Related]
30. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
31. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis. Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782 [TBL] [Abstract][Full Text] [Related]
32. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma. Zhao Y; Yan X; Wang Y; Zhou J; Yu Y Front Oncol; 2021; 11():726018. PubMed ID: 35299934 [TBL] [Abstract][Full Text] [Related]
33. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma. Zhang T; Sheng P; Jiang Y J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic, progressive and prognostic performance of m Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949 [No Abstract] [Full Text] [Related]
35. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related]
36. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis. Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732 [TBL] [Abstract][Full Text] [Related]
37. Gene Signatures and Prognostic Value of m6A RNA Methylation Regulators in Uterine Corpus Endometrial Carcinoma. Feng Y; Yao C; Shen J; Zhou J Discov Med; 2021; 31(164):111-120. PubMed ID: 35188885 [TBL] [Abstract][Full Text] [Related]
38. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma. Qi LW; Jia JH; Jiang CH; Hu JM Front Genet; 2020; 11():614566. PubMed ID: 33519919 [TBL] [Abstract][Full Text] [Related]
39. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators. Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327 [TBL] [Abstract][Full Text] [Related]
40. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment. Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]